Asset Details
Do you wish to reserve the book?
In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L
Do you wish to request the book?
In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
In vitro enzyme characterization and several inhibitors for monkeypox virus core protease I7L
2025
Overview
Abstract
Monkeypox is a zoonotic viral disease caused by the monkeypox virus, a member of the genus Orthopoxvirus within the family Poxviridae, which also includes the variola virus. On 14 August 2024, WHO Director-General declared monkeypox outbreak a public health emergency of international concern. Similar to variola virus core protease K7L, I7L could be identified as a promising target to fight against monkeypox virus. Our work provides a solid foundation as well as specific molecular tools (protease production methods, assay design, inhibitor design) that can now be used to probe the function of I7L in vitro. Notably, in this work, various reported covalent lead compounds for COVID-19 proteases were screened and A68, shikonin, and myricetin were identified as exhibiting high inhibitory activity against I7L. This work not only sheds light on effective inhibitors for the monkeypox virus core protease but also contributes to the broader search for antiviral agents targeting this enzyme.
Our work provides a solid foundation as well as specific molecular tool that can now be used to probe the function of I7L in vitro, and sheded light on effective covalent inhibitors for the monkeypox.
Publisher
Oxford University Press
Subject
/ Antiviral Agents - chemistry
/ Antiviral Agents - pharmacology
/ COVID-19
/ Enzymes
/ Humans
/ Monkeypox virus - drug effects
/ Monkeypox virus - enzymology
/ Mpox
/ Protease
/ Protease Inhibitors - chemistry
/ Protease Inhibitors - pharmacology
/ Shikonin
/ Smallpox
/ Viral Proteases - metabolism
/ Viral Proteins - antagonists & inhibitors
/ Viruses
/ Zoonoses
